Investigation Report on China's Docetaxel Market 2021-2025

SKU ID :CRI-18465158 | Published Date: 04-Jun-2021 | No. of pages: 50
1 Relevant Concepts of Docetaxel 1.1 Indications for Docetaxel 1.2 Development of Docetaxel in China 1.3 Governmental Approval of Docetaxel in China 1.4 The Impact of COVID-19 on Docetaxel Sales in China 2 Sales of Docetaxel in China, 2016-2020 2.1 Sales Value of Docetaxel 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Docetaxel 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Docetaxel by Dosage Form in China, 2016-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Form 3 Analysis of Major Docetaxel Manufacturers in China in 2020 3.1 Analysis of Market Share of Major Docetaxel Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Aventis Pharma SA 3.2.1 Enterprise Profile 3.2.2 Sales of TAXOTERE (Aventis Pharma SA's Docetaxel) in China 3.3 Jiangsu Hengrui Medicine Co., Ltd. 3.3.1 Enterprise Profile 3.3.2 Sales of Aisu (Jiangsu Hengrui Medicine Co., Ltd.'s Docetaxel) in China 3.4 Shenzhen Wanle Pharmaceutical Co.,Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of Xichun (Shenzhen Wanle Pharmaceutical Co.,Ltd.'s Docetaxel) in China 3.5 Sichuan Huiyu Pharmaceutical Co., Ltd. 3.5.1 Enterprise Profile 3.5.2 Sales of Huiyu (Sichuan Huiyu Pharmaceutical Co., Ltd.'s Docetaxel) in China 3.6 Yangtze River Pharmaceutical Group Co.,Ltd. 3.6.1 Enterprise Profile 3.6.2 Sales of Tianlun (Yangtze River Pharmaceutical Group Co.,Ltd.'s Docetaxel) in China 4 Prices of Docetaxel for Different Manufacturers in China, 2020-2021 4.1 Aventis Pharma SA (TAXOTERE) 4.2 Jiangsu Hengrui Medicine Co., Ltd. (Aisu) 4.3 Shenzhen Wanle Pharmaceutical Co., Ltd. (Xichun) 4.4 Sichuan Huiyu Pharmaceutical Co., Ltd. (Huiyu) 4.5 Yangtze River Pharmaceutical Group Co.,Ltd. (Tianlun) 5 Prospect of Chinese Docetaxel Market, 2021-2025 5.1 Influential Factors of Chinese Docetaxel Market Development 5.1.1 The Impact of COVID-19 on Chinese Docetaxel Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Docetaxel Injection Registration in China Chart Sales Value of Docetaxel Injection over the World Chart Sales Value of Docetaxel Injection in China, 2016-2020 Chart Sales Value of Docetaxel Injection in China by Region, 2016-2020 Chart Sales Volume of Docetaxel Injection in China, 2016-2020 Chart Sales Volume of Docetaxel Injection in China by Region, 2016-2020 Chart Market Share by Sales Value of Top Docetaxel Injection Manufacturers in China, 2016-2020 Chart Sales Value and Volume of TAXOTERE in China, 2016-2020 Chart Sales Value and Volume of Aisu in China, 2016-2020 Chart Sales Value and Volume of Xichun in China, 2016-2020 Chart Sales Value and Volume of Huiyu in China, 2016-2020 Chart Sales Value and Volume of Tianlun in China, 2016-2020 Chart Referential Prices of TAXOTERE in China by Region, 2020-2021 Chart Referential Prices of Aisu in China by Region, 2020-2021 Chart Referential Prices of Xichun in China by Region, 2020-2021 Chart Referential Prices of Huiyu in China by Region, 2020-2021 Chart Referential Prices of Tianlun in China by Region, 2020-2021 Chart Forecast on Sales Value of Docetaxel Injection in China, 2021-2025 Chart Forecast on Sales Volume of Docetaxel Injection in China, 2021-2025
Aventis Pharma SA,Jiangsu Hengrui Medicine Co., Ltd.,Shenzhen Wanle Pharmaceutical Co.,Ltd.,Sichuan Huiyu Pharmaceutical Co., Ltd.,Yangtze River Pharmaceutical Group Co.,Ltd.
  • PRICE
  • $2600
    $3900

Our Clients